First Trust Active Factor Small Cap ETF (AFSM)
| Assets | $38.19M |
| Expense Ratio | 0.75% |
| PE Ratio | 13.48 |
| Shares Out | 1.25M |
| Dividend (ttm) | $0.21 |
| Dividend Yield | 0.69% |
| Ex-Dividend Date | Jun 26, 2025 |
| Payout Frequency | Quarterly |
| Payout Ratio | 9.28% |
| Volume | 12,754 |
| Open | 30.30 |
| Previous Close | 30.60 |
| Day's Range | 30.20 - 30.38 |
| 52-Week Low | 24.42 |
| 52-Week High | 33.51 |
| Beta | 1.03 |
| Holdings | 332 |
| Inception Date | Dec 3, 2019 |
About AFSM
Fund Home PageThe First Trust Active Factor Small Cap ETF (AFSM) is an exchange-traded fund that mostly invests in small-cap stocks. The fund is an actively managed portfolio of US small-cap companies that exhibit exposure to one or more investing factors. AFSM was launched on Dec 3, 2019 and is issued by First Trust.
Top 10 Holdings
9.40% of assets| Name | Symbol | Weight |
|---|---|---|
| Carpenter Technology Corporation | CRS | 1.52% |
| Halozyme Therapeutics, Inc. | HALO | 1.01% |
| Cal-Maine Foods, Inc. | CALM | 0.93% |
| Corcept Therapeutics Incorporated | CORT | 0.92% |
| ADMA Biologics, Inc. | ADMA | 0.91% |
| InterDigital, Inc. | IDCC | 0.88% |
| Sprouts Farmers Market, Inc. | SFM | 0.85% |
| REV Group, Inc. | REVG | 0.81% |
| Dave Inc. | DAVE | 0.78% |
| Catalyst Pharmaceuticals, Inc. | CPRX | 0.78% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jun 26, 2025 | $0.0569 | Jun 30, 2025 |
| Mar 27, 2025 | $0.0531 | Mar 31, 2025 |
| Dec 13, 2024 | $0.0825 | Dec 31, 2024 |
| Sep 26, 2024 | $0.0165 | Sep 30, 2024 |
| Jun 27, 2024 | $0.0478 | Jun 28, 2024 |
| Mar 21, 2024 | $0.029 | Mar 28, 2024 |
Performance
AFSM had a total return of 7.96% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.42%.
News
Why Is The IPO Market Struggling? Here's What Active Managers Have To Say
Strong returns in U.S. stocks, particularly over the past two plus years, have led investors to question the relative lack of companies going public via the IPO process — as well as the potential impl...
Tech IPOs Poised For Return To Pre-Pandemic Normalcy In 2025
The new year is poised for a resurgence in tech IPOs, as lower interest rates and an investor shift to small- and mid-cap companies combine to create a more welcoming market for debuts. The current en...
January FOMC Meeting Review: The 'Fed-Amental' Attribution Error
The Federal Reserve kept rates steady and maintained a hawkish stance toward inflation while acknowledging an outstanding economy and progress in vanquishing inflationary pressure. Expectations for ra...
Broader Horizons? More Stocks Help Fuel U.S. Market Gains
Ten stocks have dominated US equity market gains for most of this year. But the rest of the market may be waking up.